Xignite to License its AWS-based Market Data Cloud Platform to Exchanges and Data Vendors
FinovateAsia 2016 -- Xignite, Inc. , the leading provider of cloud-based financial data Application Programming Interfaces (APIs) announced today the ability to license the company’s Market Data Cloud platform.
The Xignite Market Data Cloud is a cloud-based market data distribution solution that helps exchanges and financial data vendors distribute their data via massively scalable APIs from the Amazon Web Services (AWS) public cloud. The solution allows market data to remain stored in the cloud and be consumed only when, and, as needed. The Xignite solution enables exchanges, data vendors, index companies and other data originators in the $26 billion market data space to quickly upgrade or replace legacy distribution technology, while drastically reducing their infrastructure costs. Customers can deploy and independently operate the Xignite platform in their own cloud environments.
Today, most real-time and reference data is distributed via proprietary terminals, such as the Bloomberg Professional, legacy data feeds, such as those offered by Thomson Reuters, or flat files over FTP. These legacy approaches are infrastructure-heavy and require firms to replicate the market data inside their data centers at a great expense. The solution helps customers, such as financial institutions and fintech companies, innovate while drastically reducing their infrastructure costs.
“In a few years, most enterprise applications will have migrated to the cloud and billions of devices consuming such data will also be operating off the cloud,” says Stephane Dubois, CEO and founder of Xignite. “If your data is not in the cloud by 2020, your business will probably not survive.”
Xignite is the pioneer of market data in the cloud, introducing its first pure-pay commercial REST API in 2003 and its first AWS-powered API in 2008. The firm serves more than 1 trillion API requests per year and usage is growing by more than 300% year on year.
The Market Data Cloud supports:
- Delivery of data via cloud-based REST APIs (CloudAPIs), HTTP streaming to end-user devices (CloudStreaming ), HTML5 widgets (CloudWidgets ), cloud-based files delivered to AWS S3 accounts (CloudFiles ), and market event alerts (CloudAlerts ).
- Instruments in every financial asset class (equities, ETFs, mutual funds, fixed income, FX, futures, options and other derivatives).
- Delivery of real-time data , historical time series data , fundamental data , tick data and reference data from global markets.
Named one of the ten coolest brands in banking, Xignite, Inc. empowers innovation across financial services. Xignite provides cloud-based real-time and reference market data to financial services and fintech companies for easy integration with websites, apps, and software. The Xignite Market Data Cloud platform, hosted by AWS, allows companies to simplify infrastructure, scale quickly, and innovate faster. Xignite’s clients include more than 1,000 financial services, media and software companies including BMO , BlackRock , Charles Schwab , and IEX , as well as leading fintech disruptors such as Betterment , FutureAdvisor , IEX , Motif Investing , Personal Capital , Robinhood , SoFi , StockTwits , Wealthfront and Yodlee . Visit http://www.xignite.com or follow on Twitter @xignite .
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skrive dig op her og du vil løbende modtage pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
FL-GA-TELESIS11.12.2017 06:03 | pressemeddelelse
GA Telesis Launches Leveraged Finance Group with the Appointments of David Lloyd and Nolan Heske
ASTRAZENECA10.12.2017 23:47 | pressemeddelelse
AstraZeneca’s Calquence (acalabrutinib) Shows Potential in Chronic Lymphocytic Leukaemia Trials
NJ-CELGENE/BLUEBIRD-BIO10.12.2017 16:32 | pressemeddelelse
Celgene Corporation and bluebird bio Announce Updated Results from Ongoing Multicenter Phase 1 Study of bb2121 Anti-BCMA CAR T Cell Therapy in Patients with Late Stage Relapsed/Refractory Multiple Myeloma at ASH Annual Meeting
GA-GILEAD-SCIENCES/KITE10.12.2017 16:32 | pressemeddelelse
Kite Announces Long-Term Data From Pivotal ZUMA-1 Study of Yescarta™ (Axicabtagene Ciloleucel) in Patients With Refractory Large B-cell Lymphoma
MA-TAKEDA/SEATTLE10.12.2017 14:02 | pressemeddelelse
Takeda and Seattle Genetics to Present Positive Data from Phase 3 ECHELON-1 Clinical Trial Evaluating ADCETRIS® (brentuximab vedotin) in Frontline Advanced Hodgkin Lymphoma
ASTRAZENECA9.12.2017 19:02 | pressemeddelelse
AstraZeneca’s Calquence (acalabrutinib) Demonstrates Activity in Relapsed or Refractory Mantle Cell Lymphoma Trial
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum